Neural stem cells give rise to new hippocampal neurons throughout adulthood, and defects in neurogenesis may predispose an individual to mood disorders, such as major depression. Our understanding of the signals controlling this process is limited, so we explored potential pathways regulating adult hippocampal progenitor (AHP) proliferation and neuronal differentiation. We demonstrate that the mood stabilizer lithium directly expands pools of AHPs in vitro, and induces them to become neurons at therapeutically relevant concentrations. We show that these effects are independent of inositol monophosphatase, but dependent on Wnt pathway components. Both downregulation of glycogen synthase kinase-3b, a lithiumsensitive component of the canonical Wnt signaling pathway, and elevated b-catenin, a downstream component of the same pathway produce effects similar to lithium. In contrast, RNAi-mediated inhibition of b-catenin abolishes the proliferative effects of lithium, suggesting that Wnt signal transduction may underlie lithium's therapeutic effect. Together, these data strengthen the connection between psychopharmacologic treatment and the process of adult neurogenesis, while also suggesting the pursuit of modulators of Wnt signaling as a new class of more effective mood stabilizers/antidepressants.
Introduction
A large body of evidence supports the notion that central nervous system neurons are born throughout our lifetime, primarily in the hippocampal dentate gyrus, and that these neurons become functionally integrated into local circuits. 1 Defective neurogenesis or other processes that destroy hippocampal neuronal connections may induce neuropsychiatric illnesses, including mood disorders like major depression. [2] [3] [4] [5] This hypothesis is supported by evidence that diverse antidepressant therapies, including selective serotonin reuptake inhibitors (for example Prozac), monoamine oxidase inhibitors, electroconvulsive therapy and lithium, share the common ability to enhance neuronal survival and regrowth of dendritic arbors, as well as, increase hippocampal neurogenesis in vivo. [6] [7] [8] [9] Many of these effects are thought to be secondary to increased production of growth/trophic factors such as brain-derived neurotrophic factor 10, 11 (BDNF). However, mood stabilizers like lithium may directly enhance neurogenesis because they can cross directly into cells in the adult brain, essentially mimicking the actions of other, native trophic factors. 12 Recent studies show that lithium directly enhances proliferation and neurogenesis of embryonic hippocampal progenitors. 13 Unfortunately, it is difficult to extrapolate from these findings directly to the adult because these embryonic progenitors are largely predestined to become neurons, 14 while adult-derived progenitors are biased toward a glial fate. Therefore, it is necessary to test explicitly whether lithium directly stimulates adult progenitors. Ideally, this would be tested in vivo, however, the innate complexity of the adult hippocampus impedes our ability to determine if lithium directly stimulates resident precursors to become neurons or whether it indirectly enhances neurogenesis by altering the in vivo hippocampal microenvironment. Therefore, we addressed this question using a controlled in vitro environment, where it is easy to manipulate signaling pathways and measure the resulting effects on specific cell populations. At therapeutic concentrations, lithium competes with the cofactor magnesium, thereby inhibiting a broad range of enzymatic second messengers. The affected enzymes include two mediators of inositol triphosphate signaling, inositol monophosphatase (IMPase) and inositol polyphosphate 1-phosphatase (IPPase), 15, 16 glycogen synthase kinase-3 (GSK-3a/b), a downstream effector of Wnt, integrin and growth factor signaling, and numerous enzymes involved in energy metabolism. 17 Given this diversity of targets, it is not surprising that there remains disagreement over why lithium is clinically effective.
Here, we demonstrate that lithium directly enhances proliferation of adult hippocampal progenitors (AHPs) with both glial and neuronal potential via inhibition of GSK-3a/b. GSK-3b has multiple roles, including modulation of canonical Wnt signaling. Intact canonical signaling is absolutely required for correct growth and patterning of the embryonic dentate gyrus 18, 19 as well as being implicated in maintaining embryonic stem cell 20 and hematopoietic stem cell population 21 and adult neurogenesis. 22 In the present study, we show that much of lithium's effect is attributable to activation of the canonical Wnt pathway.
Materials and methods

Primary cell culture
Hippocampal progenitors from adult female Fisher 344 rats were prepared as previously described 23, 24 and maintained in minimal survival medium, which contained DMEM:F12 (Invitrogen, Carlsbad, CA, USA) þ N2 supplement (Invitrogen) þ FGF2 (Peprotech (Rocky Hill, NJ, USA); 1 ng ml
À1
). AHPs were differentiated by supplementation with 1% fetal calf serum (Hyclone, Logan, UT, USA) and either 500 ng ml À1 all trans-retinoic acid (Sigma, St Louis, MO, USA) or FGF withdrawal, as noted.
Retroviral constructs
Constitutively active DGSK-b-catenin 25 was PCR amplified from plasmid (gift of Angela Barth), cloned into pCRII-Blunt, excised as an Nsi1/NotI fragment and subcloned into Sbf1/Not1 sites of retrovirus CABIG, containing the ubiquitously strong chicken b-actin/CMV/b-globin (CAG) fusion promoter 26 driving transgene expression (gift of Ami Okada) and the MoMLV backbone (BIG: BMN-IRES-GFP; gift of Gary Nolan). pWZL-Blast, pWZL-GSK-3bKD, pWZL-GSK3bWT (gift of AM Kenney), pWZL infected cells were selected with blasticidin (Invitrogen) 5 mg ml À1 at 48 h post-transduction.
Retroviral preparation and infection
Retroviral vectors were transfected into HEK293-based packaging cell line 293GPG (gift from Dr R Mulligan) in the absence of tetracycline to produce active VSV-G pseudotyped MoMLV retrovirus and after 48 h, the medium was completely changed. Twenty-four to thirty-six hours later viral supernatants were collected, spun for 3 min at 3000 g, and filtered through 0.45-mm sterile syringe filter. Clarified supernatants were concentrated by ultracentrifugation at 50 000 g for 90 min at 4 1C and then resuspended in Optimem (Invitrogen) supplemented with polybrene (Sigma) 4-8 mg ml À1 . Final viral titers X1 Â 10 8 ml À1 were obtained consistently. AHPs were infected on day 0, then after 3 days in vitro (DIV 3), sufficient time to allow for complete reverse transcription, viral integration and transgene expression, AHPs were either pulsed with 5-bromo-2 0 -deoxyuridine (BrdU), lysed for subsequent protein analysis or allowed to differentiate.
Proliferation assays
Cells were plated into 96-well dishes at a density of 2000 cells per well. BrdU was quantified either by direct counts of immunolabeled cells or by enzymelinked immunosorbent assay (ELISA) according to the manufacturer's instructions (Roche Applied Science, Indianapolis, IN, USA), as indicated in figure legends. Mitotic index was calculated as ratio of optical density (OD) of reaction product for cells pulsed with BrdU (10 mM) for 4 h (approximately one-third of AHPs are BrdU þ at baseline), divided by OD for cells pulsed for 24 h (pulse length where 100% of cells are labeled). Initially, these data were validated against hand counts of BrdU immuno/4,6-diamidino-2-phenylindole-labeled AHPs. In these validation experiments, individual BrdU-positive cells were identified by diaminobenzidine labeling according to the manufacturer's instructions (Vector Labs, Burlingame, CA). Each plating was considered an n = 1, within each plating, there were E8 replicates per experimental condition. The data of all replicates for a given experimental condition, at specific plating, were excluded when the standard deviation of these replicates was greater than 50% of the mean OD. This primarily occurred at high lithium doses, which induced substantial cells death and cell detachment. Statistical significance was determined by one-way analysis of variance with Dunnett's correction for multiple comparisons to control (a = 0.05) or Student's t-test, two-tailed distribution, significance at Pp0.05 for individual comparisons (Analyze-It þ Excel Software).
Manually scored BrdU labeling (that is non-ELISA): after BrdU incorporation, wells were rinsed with phosphate-buffered saline (PBS) and then fixed for 10 min at room temperature with 4% paraformaldehyde. The wells were rinsed three times with PBS and then blocked for 30 min with 10% donkey serum in PBS, 0.3% Trition X-100. After blocking cells were incubated with 100 Kunitz units of DNase1 (Sigma D-5025, Bovine Pancreas) in TBS þ 1 mM MgCl 2 þ 1 mM b-mercaptoethanol pH 8.0 for 30 min at 37 1C, in order to make the BrdU epitope more accessible to antibody labeling. Wells are then incubated for 2 h with rat anti-BrdU primary antibody (1:250; Accurate Chemical & Scientific Westbury, NY, USA) in PBS, 3% donkey serum, 0.3% Triton X-100. Wells are rinsed 3 times with PBS and subsequently incubated with FITC or Cy3-conjugated donkey anti-rat secondary antibody for visualization.
ELISA-neurogenesis/gliogenesis assay
At the end of the appropriate differentiation protocol, the wells were rinsed, fixed and blocked as described above and then incubated for 2 h with mouse anti-Tuj1 (Mouse IgG2a 1:1000; Covance, Berkeley, CA, USA) or guinea-pig anti-GFAP (1:1000 Advanced Immunochemical Inc. (Long Beach, CA, USA)) in PBS, 3% donkey serum, 0.3% Triton X-100. Wells are rinsed 3 times with PBS and subsequently incubated with donkey anti-mouse or anti-guinea-pig antibodies conjugated to biotin. Vector Labs' ABC kit was then used to label the cells with avidin-biotin horseradish peroxidase complex. Wells were washed four times with PBS and then reacted with 60 mg ml À1 tetramethylbenzidine-hydrogen peroxide 0.03%. The OD at 450 nm was recorded with Molecular Dynamics plate reader. This single determinant ELISA-based assay of differentiation was validated using post hoc manual cell counting of diaminobenzidine-labeled cells in the same cultures and found that the OD of the reaction product was directly proportional to the number of immunoassayed cells, when at least 20 GFAP þ or Tuj1 þ cells were present (Supplementary Figure 1) . In non-ELISA-based assays, primary antibodies were detected with species-appropriate antibodies conjugated to one of the following fluorophores: FITC or Cy3 (1:500 Jackson Laboratories, Bar Harbor, ME, USA), Alexa 488, 555, 594 (1:1000; Invitrogen/ (Molecular Probes-Invitrogen, Carlsbad, CA, USA)).
b-Catenin knockdown All transfections were carried out using Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions. AHPs were transfected with either an RNAi Duplex against rat b-catenin, 27 green fluorescent protein (GFP) or luciferase (Dharmacon, Lafayette, CO, USA), plus either the plasmid pEGFP-C3 (Clontech, Palo Alto, CA, USA) or pEF6-GFP (eGFP from pEGFP-C1 cloned out as T/A PCR fragment into pEF6-V5-His-Topo (Invitrogen)). These fragments express GFP and confer antibiotic resistance to G418 (600 mg ml À1 ) or blasticidin (5-10 mg ml À1 ). AHP's were co-transfected and selected according to the following schedule: DIV 1 Transfect, DIV 2 add G418 (500-750 mg ml À1 ), DIV 3 remove antibiotic and then retransfect, D4-5 select with G418 (or Blasticidin 7 mg ml À1 ). Prior to adding antibiotics on DIV 2, fewer than 20% of cells expressed GFP. However, over 75% of AHPs expressed GFP following two rounds of transfection, coupled with antibiotic selection. On DIV 6, culture medium was supplemented with lithium (5 mM). After 24 h, cells were pulsed for 1 h with BrdU (10 mM) then fixed and immunolabeled with antibodies against BrdU.
Results
Lithium promotes expansion of neural precursors and neurogenesis
Although lithium (Li þ ) enhances neurogenesis in the adult hippocampus, it is unknown if it acts directly on resident neural precursors. For example, lithium could act indirectly by stimulating neurons or glia to secrete diffusible factors that increase survival of newly born neurons (for example neurotrophins or arachidonic acid metabolites 28, 29 ). Therefore, we used cultured adult hippocampal precursors (AHPs) as a well-controlled model system to test if lithium directly regulates AHP proliferation and/or development. Primary AHP cultures were prepared, as previously described 23, 24 then plated onto a laminin/ polyornithine substrate at low-density (10 4 /cm 2 ). Initially, these monolayer cultures ( Figure 1a) were maintained in minimal survival medium, which supports their survival, but not rapid expansion 30, 31 and then incubated in medium containing varying does of LiCl (Figure 1b) .
We assessed the proliferative effects of increasing concentrations of lithium (0-10 mM). These doseresponse experiments (n = 12), summarized in Figure  1c , show that 48 h of exposure to lithium significantly increased the mitotic index, more than doubling the fraction of cells traversing the cell cycle at 6 mM LiCl. Of note, concentrations of lithium greater than 6 mM induced substantial death and detachment of AHPS from their substrate, manifesting as a precipitous decline in BrdU incorporation (8.8%72.4 at 10 mM). This is consistent with the clinically observed toxicity of lithium at these high concentrations.
Fetal neural progenitors have a relative bias towards a neuronal fate. As such, a recent in vitro study of embryonic neural precursors (ENPs) revealed that lithium preferentially expanded the neuronal pool, at the expense of astrocyte formation. 13 However, adult hippocampal precursors readily differentiate into both neurons and glia in vitro. This raises the question of whether lithium is selectively neurogenic 13 or it simply increased the number of fetal progenitors already destined to become neurons. Since AHPs have a greater gliogenic potential, relative to ENPs, 14 we assessed the effects of lithium on differentiating AHPs. We plated and subsequently differentiated progenitors in the presence of varying LiCl concentrations, under standard conditions (Figures 2c and d) . Fewer than 2% of the differentiated cells expressed markers for neurons (Tuj1) or astrocytes (GFAP), in the absence of LiCl pretreatment. In contrast, lithium differentially expanded both neuronal and astrocyte pools, depending on concentration. High-dose lithium (6 mM) increased gliogenesis fivefold over control (Figure 2c ), paralleling the doseresponse relationship seen in Figure 1b (overall proliferation), while reducing neurogenesis by 90% (Figure 2d ). In contrast, the less toxic and more therapeutically relevant lithium concentrations (E1-2 mM) maximally stimulate neurogenesis to nearly threefold over control (Figure 2d ), but do not significantly increase gliogenesis (Figure 2c ).
AHP proliferation is independent of inositol depletion
We next asked, what is the mechanism of lithiuminduced proliferation of adult neural progenitors? At therapeutically relevant concentrations, lithium inhibits GSK-3b, a component of the canonical Wnt signaling pathway, as well as the enzymes IMPase and inositol polyphosphatase (IPPase), key steps in inositol triphosphate signaling. 17 Lithium shares these properties with other mood stabilizers, as well.
Specifically, valproic acid inhibits both GSK-3b and IMPase/IPPase, while carbamazepine blocks only IMPase/IPPase. 17, 32 Since all three mood stabilizers alter inositol signaling, but not GSK-3b, we tested whether these drugs were equally effective at increasing AHP proliferation. We applied clinically effective concentrations of carbamazepine (50 mM), valproic acid (500 mM) and lithium (2 mM) to AHP for 48 h then pulsed with BrdU for 1 h prior to fixation ( Figure  3a) . Lithium significantly increased AHP proliferation by 60% vs control. Consistent with previous studies, valproic acid reduced proliferation by 40%, 33 while carbamazepine had no effect. 34 Next, we tested if overcoming IMPase/IPPase inhibition could block lithium-induced neurogenesis. High concentrations of extracellular myo-inositol (10 mM) circumvent lithium-induced IMPase/IPP inhibition in cultured neurons. 16 However, we found that the addition of myo-inositol (10 mM) did not alter the ability of lithium (1-10 mM) to enhance AHP proliferation (Figure 3b) . Similarly, the addition of inositol did not affect lithium's ability to enhance either neuronal or glial differentiation (Figure 3c ). Together, these data indicate that IMPase inhibition does not mediate lithium's expansion of adult neural progenitor pools or effects on differentiation.
GSK-3b inhibition and b-catenin activation recapitulates lithium-induced AHP proliferation
We examined whether the proliferative effects of lithium are attributable to GSK-3b inhibition. To accomplish this, we retrovirally transduced AHPs with either a wild-type GSK-3b or a dominantnegative GSK-3b, which should mimic lithium inhibition (GSK-3bKD 'kinase-dead' 35, 36 ). We observed that downregulation of GSK-3b activity, by GSK-3bKD overexpression, significantly enhanced AHP proliferation ( Figure 4 ) by nearly twofold, while overexpression of wild-type GSK-3b (that is upregulation of GSK-3b activity) halved proliferation.
Although Wnt, insulin, integrins, growth factors like EGF or FGF and endocannabinoids [37] [38] [39] [40] signal through GSK-3b, a distinguishing feature of the canonical Wnt pathway is that GSK-3b phosphorylates b-catenin, targeting it for degradation. Binding of Wnt to Frizzled receptors on the cell surface downregulates GSK-3b, thereby elevating intracellular bcatenin levels. When abundant, b-catenin translocates to the nucleus where it binds to and activates the LEF/TCF family of HMG-box containing transcription factors. Since canonical Wnt signaling is required for appropriate proliferation of embryonic dentate progenitors, 19, 41 we tested the hypothesis that GSK-3b-induced accumulation of b-catenin was responsible for enhancing AHP proliferation and differentiation. an unexpectedly substantial decrease in survival, akin to the toxic effects of higher doses of lithium (data not shown). Next, we observed that retroviral overexpressing of b-catenin, in differentiating AHPs, induced a 2.4-fold increased the total number of neurons (Figure 5b ) and produced a nearly twofold trend toward increased astrocyte production ( Figure  5c ). Observing that elevated b-catenin increases both neurons and glia formation in proportion to it effects on proliferation, raises the possibility that canonical activation primarily acts to expand pools of dividing multipotent progenitors, rather than affecting cell fate decisions.
b-Catenin activates canonical Wnt pathway to enhance proliferation Our data strongly suggest that lithium drives expansion of adult neural progenitors through activation of the canonical Wnt pathway, which is mediated via b-catenin/Tcf transcriptional activity. We formally tested this hypothesis by knocking down b-catenin with transfected RNAi duplexes, in the presence of lithium (5 mM) and measuring resulting levels of AHP proliferation. We accomplished this knockdown using an RNAi duplex that is efficacious in developing neurons. 27 Consistent with our previous finding, Li þ increased AHP proliferation, compared to the control ( Figure 6 ). In contrast, co-transfection with anti-b-catenin RNAi plus GFP-plasmid, substantially reduced lithium-induced AHP proliferation, as compared to those transfected with GFP alone. Together, with our previous findings (Figure 3 ), these data indicate that intact canonical Wnt signaling in AHPs is necessary for lithium's effects on proliferation by directly activating the canonical signaling machinery.
Discussion
Lithium activates canonical Wnt signaling to drive proliferation Lithium enhances adult hippocampal neurogenesis in vivo. 7, 13 But, these previous reports do not address whether lithium acts directly on resident precursors, nor do these previous data identify its intracellular mechanism of action. Certainly, no single target mediates all of the effects that lithium can have in the central nervous system. However, its therapeutic effect in mood disorders is most often ascribed to either inositol depletion GSK-3b inhibition, although GSK-3b inhibition mimics lithium-induced proliferation. AHPs were infected with either the empty retrovirus pWZL(Con), pWZL-GSK-3bKD, containing a dominant-negative, 'kinase dead' GSK-3b (KD), or wildtype GSK-3b. Overexpression of GSK-3bKD, which should mimic lithium, significantly increased the mitotic index by twofold, while overexpression of wild-type GSK-3b reduced proliferation, compared to control. AHP, adult hippocampal progenitor. effects on other messenger systems have been identified. Our data strongly suggest that inositol depletion is not involved in lithium-induced neurogenesis. In contrast, GSK-3b inhibition mimics lithium-induced AHP proliferation. This ubiquitous enzyme is a common mediator of several developmental signals, including the canonical Wnt signaling pathway. We demonstrate that elevation of b-catenin, a sine qua non of canonical signaling, expands the population of dividing AHPS and almost equally promotes increased neurogenesis and gliogenesis. In contrast, RNAi-mediated downregulation of b-catenin suppresses the effects of lithium. Together, these data indicate that lithium regulates adult neural progenitors through activation of the Canonical Wnt pathway. Although these data are strongly suggestive, they do not absolutely exclude the possibility that there are other targets, besides GSK-3b, that mediate lithium's neurogenic effects in vivo. However, they are very consistent with an important new study showing that lithium administration and b-catenin activation produce a similar behavioral phenotype. 42 Adult vs embryonic neural progenitors Previous in vitro studies have focused on lithium's neurogenic effects in ENPs, 13, 43 rather than adult progenitors, which often behave differently than their embryonic counterparts.
14 Our findings are in general agreement with previous reports in ENPs. However, not surprisingly, several notable differences exist between the behavior of ENPs and our observations of adult progenitors. A previous study found that lithium enhanced neurogenesis from ENPs across a wide range of concentrations (1-5 mM). 13 In AHPs, we observed a sharp dose-related falloff in neurogenesis at lithium concentrations above 1-2 mM. Because 1 mM is the clinically effective concentration, this observation provides further support for a link between the clinical efficacy of mood stabilizers/ antidepressants and their ability to regenerate neuronal circuitry. Second, we observed that lithium is strongly gliogenic at higher concentrations (5-6 mM) in adult neural progenitors. In contrast, lithium exerted an exclusively neurogenic effect upon ENPs across all concentrations. 13 This may reflect an innate tendency for proliferating AHPs to form astrocytes when not exposed to the strong neurogenic signals that are present in vivo. Alternatively, high lithium levels may be selectively toxic to newborn adult neurons, possibly through its known inhibition of enzymes critical to energy metabolism and nucleoside processing. 15, 16, 44 This would be consistent with the general finding that adult neurons are more susceptible to both toxic and energy deprivationtype insults than either adult glia or embryonic neurons.
Lastly, these results may further encourage already widespread efforts to develop clinically useful small molecule inhibitors of GSK-3b, 45 because of the enticing link between neurogenesis and major mood disorders. 6, 46 However, the fact that GSK-3b inhibition is a critical step is numerous signaling pathways and that overinhibition of GSK-3b can be lethal to neurons 47, 48 means that even the most specific GSK3b inhibitor may never be clinically superior to lithium. Since lithium activates the Wnt signaling cascade, future drugs targeting this pathway may serve as a new class of more effective mood stabilizers.
